Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.45 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | PNMT | P11086 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.40 |
| ▸ | HTR3A | P46098 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30162631 | 0.82 | KMT2A (1.00) | KMT2AALDH1A1MAPTGLAHPGD | |
| SCHEMBL377259 | 0.82 | KMT2A (1.00) | KMT2AALDH1A1MAPTGLAHPGD | |
| SCHEMBL3387991 | 0.82 | KMT2A (0.62) | KMT2AALDH1A1MAPTGLAHPGD | |
| SCHEMBL29518150 | 0.81 | KMT2A (0.70) | KMT2AALDH1A1MAPTGLAHPGD | |
| SCHEMBL8735682 | 0.81 | KMT2A (0.70) | KMT2AALDH1A1MAPTGLAHPGD | |
| SCHEMBL120913 | 0.81 | KMT2A (0.70) | KMT2AALDH1A1MAPTGLAHPGD | |
| SCHEMBL681071 | 0.81 | KMT2A (0.70) | KMT2AALDH1A1MAPTGLAHPGD | |
| SCHEMBL13067261 | 0.81 | KMT2A (0.70) | KMT2AALDH1A1MAPTGLAHPGD | |
| SCHEMBL21550243 | 0.79 | KMT2A (0.44) | KMT2AALDH1A1MAPTNPSR1LOXL2 | |
| SCHEMBL317874 | 0.78 | TLR8 (0.62) | KMT2AALDH1A1MAPTGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1961733-B1 | METHOD FOR SELECTIVELY PRODUCING PRIMARY AMINE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2014-08-20 | — | — | EP | disclosed |
| CN-103102303-A | Benzylamine derivatives as CETP inhibitors | REDDY US THERAPEUTICS INC | 2013-05-15 | — | — | CN | disclosed |
| US-8269044-B2 | Method for selectively producing primary amine compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-09-18 | — | — | US | disclosed |
| US-20090281325-A1 | METHOD FOR SELECTIVELY PRODUCING PRIMARY AMINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-11-12 | — | — | US | disclosed |
| EP-1961733-A1 | METHOD FOR SELECTIVELY PRODUCING PRIMARY AMINE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281325-A1 | METHOD FOR SELECTIVELY PRODUCING PRIMARY AMINE COMPOUND | NAT1, AADAC, AOC3 | KMT2A 351/4885ALDH1A1 153/4885MAPT 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.